Про Alkahest, inc.

Про компанію

Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline. It collaborates with Barcelona, Spain-based Grifols, a global healthcare company producer of plasma therapies. The company’s breakthrough research has demonstrated that factors in the blood plasma of young mice are able to reverse brain deficits in normal aging and Alzheimer’s disease models in mice. The company was founded in 2014 and is based in San Carlos, California.